These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

980 related items for PubMed ID: 16569594

  • 1. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM, Borleri G, Conti E, Ciocca A, Salvi A, Micò C, Introna M, Rambaldi A.
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [Abstract] [Full Text] [Related]

  • 2. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E, Wölfel C, Köhler S, Nonn M, Kaus N, Schnürer E, Meyer RG, Wehler TC, Huber C, Wölfel T, Hartwig UF, Herr W.
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
    Daudt L, Maccario R, Locatelli F, Turin I, Silla L, Montini E, Percivalle E, Giugliani R, Avanzini MA, Moretta A, Montagna D.
    J Immunother; 2008 May; 31(4):385-93. PubMed ID: 18391757
    [Abstract] [Full Text] [Related]

  • 4. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM, van Luxemburg-Heijs SA, Rijnbeek M, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [Abstract] [Full Text] [Related]

  • 5. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C, Wang Z, Lacey SF, Lalimarmo MM, Krishnan A, Longmate J, Diamond DJ.
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [Abstract] [Full Text] [Related]

  • 6. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [Abstract] [Full Text] [Related]

  • 7. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B, Horn PA, Daubert C, Khattab B, Blasczyk R.
    Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
    [Abstract] [Full Text] [Related]

  • 8. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 9. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb 01; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 10. Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
    Wang ZD, Li D, Huang XJ.
    Chin Med J (Engl); 2010 Apr 05; 123(7):912-6. PubMed ID: 20497687
    [Abstract] [Full Text] [Related]

  • 11. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.
    Chen J, Schmitt A, Bunjes D, Chen B, Schmitt M.
    Int J Oncol; 2007 May 05; 30(5):1119-27. PubMed ID: 17390013
    [Abstract] [Full Text] [Related]

  • 12. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.
    Br J Haematol; 2006 Jan 05; 132(1):56-65. PubMed ID: 16371020
    [Abstract] [Full Text] [Related]

  • 13. Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.
    Fujiwara H, Sconocchia G, Melenhorst J, Eniafe R, Nakamura R, Hensel N, Barrett AJ.
    Bone Marrow Transplant; 2003 Aug 05; 32(4):371-8. PubMed ID: 12900773
    [Abstract] [Full Text] [Related]

  • 14. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK, Lane TA, Ball ED.
    Exp Hematol; 2008 Apr 05; 36(4):486-94. PubMed ID: 18249062
    [Abstract] [Full Text] [Related]

  • 15. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G, Niethammer D, Einsele H.
    Exp Hematol; 2004 Mar 05; 32(3):282-9. PubMed ID: 15003314
    [Abstract] [Full Text] [Related]

  • 16. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T, Richard C, Joachim S, Scheible MH, Schumm M, Hamprecht K, Martin D, Jahn G, Handgretinger R, Lang P.
    J Immunother; 2008 Mar 05; 31(2):199-206. PubMed ID: 18481389
    [Abstract] [Full Text] [Related]

  • 17. Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential.
    Liepert A, Grabrucker C, Kremser A, Dreyssig J, Ansprenger C, Freudenreich M, Kroell T, Reibke R, Tischer J, Schweiger C, Schmid C, Kolb HJ, Schmetzer H.
    Cell Immunol; 2010 Mar 05; 265(1):23-30. PubMed ID: 20663492
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
    Peggs KS, Mackinnon S.
    Hum Immunol; 2004 May 05; 65(5):550-7. PubMed ID: 15172456
    [Abstract] [Full Text] [Related]

  • 19. A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.
    Serody JS, Brecher ME, Dent G, Bentley SA, Frelinger JA, Shea TC.
    Cancer Res; 1997 Apr 15; 57(8):1547-53. PubMed ID: 9108458
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic HLA-matched donor dendritic cells loaded with patient leukemic blasts preferentially induce CD4-positive leukemia-reactive donor lymphocytes.
    Thomas-Kaskel AK, Portugal TG, Herchenbach D, Houet L, Veelken H, Finke J.
    Acta Haematol; 2007 Apr 15; 117(4):226-35. PubMed ID: 17308369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.